These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34369124)

  • 1. COVID-19 Tests the Limits of Biodiversity Laws in a Health Crisis: Rethinking "Country of Origin" for Virus Access and Benefit-sharing.
    Humphries F; Rourke M; Berry T; Englezos E; Lawson C
    J Law Med; 2021 Mar; 28(3):684-706. PubMed ID: 34369124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Who Are Indigenous and Local Communities and What Is Traditional Knowledge for Virus Access and Benefit-sharing? A Textual Analysis of the Convention on Biological Diversity and Its Nagoya Protocol.
    Rourke MF
    J Law Med; 2018 Apr; 25(3):707-726. PubMed ID: 29978663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balanced Options for Access and Benefit-Sharing: Stakeholder Insights on Provider Country Legislation.
    Sirakaya A
    Front Plant Sci; 2019; 10():1175. PubMed ID: 31632420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discussing the Drawbacks of the Implementation of Access and Benefit Sharing of the Nagoya Protocol Following the COVID-19 Pandemic.
    Mueni Katee S; Keambou Tiambo C
    Front Public Health; 2021; 9():639581. PubMed ID: 34956996
    [No Abstract]   [Full Text] [Related]  

  • 5. Genebank Operation in the Arena of Access and Benefit-Sharing Policies.
    Brink M; van Hintum T
    Front Plant Sci; 2019; 10():1712. PubMed ID: 32038684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Explanation of the Nagoya Protocol on Access and Benefit Sharing and its implication for microbiology.
    Smith D; da Silva M; Jackson J; Lyal C
    Microbiology (Reading); 2017 Mar; 163(3):289-296. PubMed ID: 28086069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access and benefit-sharing by the European Virus Archive in response to COVID-19.
    Sett S; Dos Santos Ribeiro C; Prat C; Haringhuizen G; ; Scholz AH
    Lancet Microbe; 2022 Apr; 3(4):e316-e323. PubMed ID: 34806057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access and Benefit Sharing Under the Nagoya Protocol-
    Heinrich M; Scotti F; Andrade-Cetto A; Berger-Gonzalez M; Echeverría J; Friso F; Garcia-Cardona F; Hesketh A; Hitziger M; Maake C; Politi M; Spadafora C; Spadafora R
    Front Pharmacol; 2020; 11():765. PubMed ID: 32581783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access by Design, Benefits if Convenient: A Closer Look at the Pandemic Influenza Preparedness Framework's Standard Material Transfer Agreements.
    Rourke MF
    Milbank Q; 2019 Mar; 97(1):91-112. PubMed ID: 30637812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convention on Biological Diversity (CBD) and the Nagoya Protocol: Implications and Compliance Strategies for the Global Coffee Community.
    Lachenmeier DW; Montagnon C
    Foods; 2024 Jan; 13(2):. PubMed ID: 38254555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Access and benefit sharing--The perspective of basic research.
    Beck E
    Phytomedicine; 2019 Feb; 53():302-307. PubMed ID: 30503101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of the Nagoya Protocol in the European Union and in Germany.
    Greiber T
    Phytomedicine; 2019 Feb; 53():313-318. PubMed ID: 30392747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The U.S. Culture Collection Network Responding to the Requirements of the Nagoya Protocol on Access and Benefit Sharing.
    McCluskey K; Barker KB; Barton HA; Boundy-Mills K; Brown DR; Coddington JA; Cook K; Desmeth P; Geiser D; Glaeser JA; Greene S; Kang S; Lomas MW; Melcher U; Miller SE; Nobles DR; Owens KJ; Reichman JH; da Silva M; Wertz J; Whitworth C; Smith D
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Need for sustainable biobanking networks for COVID-19 and other diseases of epidemic potential.
    Peeling RW; Boeras D; Wilder-Smith A; Sall A; Nkengasong J
    Lancet Infect Dis; 2020 Oct; 20(10):e268-e273. PubMed ID: 32717208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 25 years after the `Rio Convention'--Lessons learned in the context of sustainable development and protecting indigenous and local knowledge.
    Heinrich M; Hesketh A
    Phytomedicine; 2019 Feb; 53():332-343. PubMed ID: 30318154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sharing the benefits of biodiversity: a new international protocol and its implications for research and development.
    Oliva MJ
    Planta Med; 2011 Jul; 77(11):1221-7. PubMed ID: 21674434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Battling COVID-19 pandemic waves in six South-East Asian countries: A real-time consensus review.
    Rampal L; Liew BS; Choolani M; Ganasegeran K; Pramanick A; Vallibhakara SA; Tejativaddhana P; Hoe VC
    Med J Malaysia; 2020 Nov; 75(6):613-625. PubMed ID: 33219168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the changing role of global public health in biodiversity conservation.
    Smith W
    Ambio; 2022 Mar; 51(3):485-493. PubMed ID: 34115346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open Access DNA, RNA and Amino Acid Sequences: The Consequences and Solutions for the International Regulation of Access and Benefit Sharing.
    Lawson C; Rourke M
    J Law Med; 2016; 24(1):96-118. PubMed ID: 30136777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19-A Novel Zoonotic Disease: A Review of the Disease, the Virus, and Public Health Measures.
    Mackenzie JS; Smith DW
    Asia Pac J Public Health; 2020 May; 32(4):145-153. PubMed ID: 32475144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.